• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DODAB 纳米尺寸阳离子双层片段对 的影响。

Effect of DODAB Nano-Sized Cationic Bilayer Fragments against .

机构信息

Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.

Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.

出版信息

Molecules. 2020 Dec 5;25(23):5741. doi: 10.3390/molecules25235741.

DOI:10.3390/molecules25235741
PMID:33291367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7730371/
Abstract

The dioctadecyldimethylammonium bromide (DODAB) is a double-chained cationic lipid with potent bactericide and fungistatic activities; however, its toxicity on protozoan parasites is still unknown. Here, we show the antileishmanial activity of DODAB nano-sized cationic bilayer fragments on stationary-phase promastigotes and amastigotes of , the causative agent of cutaneous leishmaniasis. Upon treatment with DODAB, we analyzed the parasite surface zeta-potential, parasite viability, cellular structural modifications, and intracellular proliferation. The DODAB cytotoxic effect was dose-dependent, with a median effective concentration (EC) of 25 µM for both life-cycle stages, comparable to the reported data for bacteria and fungi. The treatment with DODAB changed the membrane zeta-potential from negative to positive, compromised the parasite's morphology, affected the cell size regulation, caused a loss of intracellular organelles, and probably dysregulated the plasma membrane permeability without membrane disruption. Moreover, the parasites that survived after treatment induced small parasitophorous vacuoles and failed to proliferate inside macrophages. In conclusion, DODAB displayed antileishmanial activity, and it remains to be elucidated how DODAB acts on the protozoan membrane. Understanding this mechanism can provide insights into the development of new parasite-control strategies.

摘要

双十八烷基二甲基溴化铵(DODAB)是一种双链阳离子脂质,具有很强的杀菌和抑菌活性;然而,其对原生动物寄生虫的毒性尚不清楚。在这里,我们展示了 DODAB 纳米尺寸阳离子双层片段对引起皮肤利什曼病的 的静止期前鞭毛体和无鞭毛体的抗利什曼原虫活性。在用 DODAB 处理后,我们分析了寄生虫表面 ζ-电位、寄生虫活力、细胞结构修饰和细胞内增殖。DODAB 的细胞毒性作用呈剂量依赖性,对两种生活阶段的中效浓度(EC)均为 25µM,与报道的细菌和真菌数据相当。DODAB 处理将膜 ζ-电位从负变为正,破坏寄生虫的形态,影响细胞大小调节,导致细胞内细胞器丢失,并可能在不破坏膜的情况下使质膜通透性失调。此外,治疗后存活的寄生虫诱导小寄生空泡,并且无法在巨噬细胞内增殖。总之,DODAB 表现出抗利什曼原虫活性,但其对原生动物膜的作用方式仍有待阐明。了解这种机制可以为开发新的寄生虫控制策略提供思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/59081edb7a16/molecules-25-05741-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/b18802a7a4ec/molecules-25-05741-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/f0e63c889c25/molecules-25-05741-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/59081edb7a16/molecules-25-05741-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/b18802a7a4ec/molecules-25-05741-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/f0e63c889c25/molecules-25-05741-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0330/7730371/59081edb7a16/molecules-25-05741-g004.jpg

相似文献

1
Effect of DODAB Nano-Sized Cationic Bilayer Fragments against .DODAB 纳米尺寸阳离子双层片段对 的影响。
Molecules. 2020 Dec 5;25(23):5741. doi: 10.3390/molecules25235741.
2
Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.米替福新的非经典生物电子等排体1,2,3-三唑盐对亚马逊利什曼原虫的作用。
Bioorg Med Chem. 2017 Jun 15;25(12):3034-3045. doi: 10.1016/j.bmc.2017.03.051. Epub 2017 Mar 28.
3
N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.N-丁基-[1-(4-甲氧基)苯基-9H-β-咔啉]-3-甲酰胺可阻止亚马逊利什曼原虫的胞质分裂。
Antimicrob Agents Chemother. 2014 Dec;58(12):7112-20. doi: 10.1128/AAC.03340-14. Epub 2014 Sep 15.
4
In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.(-)α-红没药醇作为抗亚马逊利什曼原虫潜在药物的体外评价
Exp Parasitol. 2015 Jan;148:66-72. doi: 10.1016/j.exppara.2014.10.001. Epub 2014 Nov 5.
5
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.对一种氯喹啉衍生物针对能够引起皮肤利什曼病和内脏利什曼病的利什曼原虫物种的体外和体内抗利什曼活性进行评估。
Exp Parasitol. 2019 Apr;199:30-37. doi: 10.1016/j.exppara.2019.02.019. Epub 2019 Feb 25.
6
Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.氨基脲衍生物作为利什曼病中有前景的治疗选择。
Exp Parasitol. 2019 Jun;201:57-66. doi: 10.1016/j.exppara.2019.04.003. Epub 2019 Apr 17.
7
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.氯碘羟喹对利什曼原虫和亚马逊利什曼原虫种的抗利什曼原虫活性、细胞毒性和作用机制。
Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):236-246. doi: 10.1111/bcpt.12990. Epub 2018 Apr 6.
8
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.一种氟喹诺酮衍生物对婴儿利什曼原虫和亚马逊利什曼原虫的体外和体内抗利什曼活性。
Acta Trop. 2019 Mar;191:29-37. doi: 10.1016/j.actatropica.2018.12.036. Epub 2018 Dec 23.
9
Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.他莫昔芬对利什曼原虫有效,并能使含有亚马逊利什曼原虫(Leishmania)无鞭毛体的寄生泡迅速碱化。
J Antimicrob Chemother. 2007 Sep;60(3):526-34. doi: 10.1093/jac/dkm219. Epub 2007 Jun 21.
10
Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana .壳聚糖及其衍生物对利什曼原虫和墨西哥利什曼原虫的活性。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01772-19.

引用本文的文献

1
DODAB-ODN lipoplex structure is highly dependent on ODN concentration: A multitechnique experimental study.二油酰基磷脂酰乙醇胺-寡脱氧核苷酸脂质体复合物结构高度依赖于寡脱氧核苷酸浓度:一项多技术实验研究。
Biochem Biophys Rep. 2025 Jul 19;43:102128. doi: 10.1016/j.bbrep.2025.102128. eCollection 2025 Sep.
2
Supramolecular Nanostructures for Vaccines.用于疫苗的超分子纳米结构
Biomimetics (Basel). 2021 Dec 29;7(1):6. doi: 10.3390/biomimetics7010006.
3
In Silico Characterization of Calcineurin from Pathogenic Obligate Intracellular Trypanosomatids: Potential New Biological Roles.

本文引用的文献

1
Protein glycosylation in spp. spp. 中的蛋白糖基化
Mol Omics. 2020 Oct 12;16(5):407-424. doi: 10.1039/d0mo00043d.
2
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity.一种用于利什曼病药物发现的多物种表型筛选测定法表明,活性化合物表现出高度的物种特异性。
Molecules. 2020 May 30;25(11):2551. doi: 10.3390/molecules25112551.
3
Biomimetic Lipid Polymer Nanoparticles for Drug Delivery.用于药物递送的仿生脂质聚合物纳米颗粒
计算机模拟分析致病专性内共生体中的钙调神经磷酸酶:潜在的新生物学作用。
Biomolecules. 2021 Sep 7;11(9):1322. doi: 10.3390/biom11091322.
Methods Mol Biol. 2020;2118:45-60. doi: 10.1007/978-1-0716-0319-2_4.
4
Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation.用于治疗皮肤利什曼病的局部葡聚糖胶体纳米载体:体外皮肤保留和体内评价。
Eur J Pharm Sci. 2020 Apr 30;147:105295. doi: 10.1016/j.ejps.2020.105295. Epub 2020 Mar 5.
5
TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection.TLR9/MyD88/TRIF 信号激活利什曼原虫感染宿主免疫抑制性 CD200。
JCI Insight. 2019 May 16;4(10). doi: 10.1172/jci.insight.126207.
6
Short communication: Activity of nisin, lipid bilayer fragments and cationic nisin-lipid nanoparticles against multidrug-resistant Staphylococcus spp. isolated from bovine mastitis.短篇通讯:来自奶牛乳腺炎的耐多药葡萄球菌分离株中,乳链菌肽、脂双层片段和阳离子乳链菌肽-脂质纳米粒的活性。
J Dairy Sci. 2019 Jan;102(1):678-683. doi: 10.3168/jds.2018-15171. Epub 2018 Nov 8.
7
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.针对三锥虫病(重点是利什曼病)的药物发现挑战。
Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):430-439. doi: 10.1016/j.ijpddr.2018.09.006. Epub 2018 Sep 28.
8
Leishmaniasis.利什曼病。
Lancet. 2018 Sep 15;392(10151):951-970. doi: 10.1016/S0140-6736(18)31204-2. Epub 2018 Aug 17.
9
Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects.利什曼原虫中经过基因验证的药物靶点:当前认知与未来展望
ACS Infect Dis. 2018 Apr 13;4(4):467-477. doi: 10.1021/acsinfecdis.7b00244. Epub 2018 Feb 9.
10
Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: evaluation of humoral response.双十八烷基二甲基溴化铵(DODAB-BF)作为一种新佐剂在小鼠中的应用:用于母婴免疫接种以预防脑膜炎奈瑟菌的体液免疫反应评价。
Pathog Dis. 2018 Feb 1;76(1). doi: 10.1093/femspd/ftx128.